In 2019, the federal government released its Ending the HIV Epidemic initiative seeking to reduce the number of new HIV infections in the United States by 75 percent by 2025, and then by at least 90 percent by 2030, for an estimated 250,000 total HIV infections averted. On World AIDS Day in 2018, Governor Murphy committed to ending the HIV epidemic in our state by 2025. NJDOH, in partnership with the New Jersey Taskforce to End the HIV Epidemic, recently released “A Strategic Plan to End HIV in New Jersey by 2025.”
NJ’s Statewide plan highlights three main goals:
- Reduce the number of new HIV infections by 75%
- Promote access to testing so that 100% of persons living with HIV/AIDS know their status
- Promote access to linkage to care so that 90% of persons diagnosed with HIV/AIDS are virally suppressed
State Plan
New Jersey’s Strategic Plan to End the HIV Epidemic by 2025 [PDF]
Federal Plan
Ending the HIV Epidemic: New Jersey's Strategic Plan (Essex and Hudson Counties) [PDF]
Epidemiological Profiles
Hudson County [PDF]
- For more information on Ending the HIV epidemic in NJ, visit:
- For information on CDC, Ending the HIV Epidemic in the US, visit:
Treatment as Prevention (TasP) Overview
Refers to taking HIV medicine to prevent the sexual transmission of HIV and it is one of the most highly effective options for preventing HIV transmission. People with HIV who take HIV medicine (called antiretroviral therapy or ART) as prescribed and get and keep an undetectable viral load—a very low level of HIV in the blood—can live long and healthy lives and will not transmit HIV to their HIV-negative partners through sex. This is sometimes called undetectable = untransmittable (U=U).
TasP works when a person with HIV takes HIV medicine exactly as prescribed and has regular follow-up care, including routine viral load tests to ensure their viral load stays undetectable.
Useful Resources
For more CDC information on TasP and U=U, visit cdc.gov/hiv/risk/art/index.html
For more information on TasP and U=U, visit: